Latest Pharma acquisation news Sep 23, 2020... Sep 23
Oxford Nanopore Technologies Sign Non-Exclusive Licensing Agreement for Genetics Research’s Patented DNA Negative Enrichment Technology Platform ... Sep 23
-Advertisements-